
India and the Patent Wars : Pharmaceuticals in the New Intellectual Property Regime
- English
- ePUB (mobile friendly)
- Available on iOS & Android
India and the Patent Wars : Pharmaceuticals in the New Intellectual Property Regime
About this book
India and the Patent Wars examines struggles over patents and access to medicine among pharmaceutical producers, activists and others under a new global intellectual property regime. In the past two decades, intellectual property rights have expanded throughout the globe creating a world in which protections for patents and copyrights have increased and a growing range of knowledge and practices are claimed as property. Driving these changes are U.S. court decisions, the policies of multinational corporations, and the World Trade Organization (WTO). Resistance to this regime has emerged in low-income countries among public health activists concerned about the rising cost of medicines for HIV/AIDS and indigenous peoples who now see their knowledge as vulnerable and pursue ownership claims for their medical and cultural practices.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Acknowledgments
- Note on Names of Medications
- Introduction
- 1. The Invention and Expansion of Intellectual Property
- 2. The New Patent Regime: The Activists and Their Allies
- 3. Ayurvedic Dilemmas: Innovation, Ownership, and Resistance
- 4. The Gilead Model and the Perspective of Big Pharma
- 5. The View from Hyderabad: The “Indian” Pharmaceutical Industry and the New Patent Regime
- Conclusion
- Notes
- References
- Index